비교리스트

 카트 문의
시장보고서
상품코드
1563836

세계의 여성 건강 진단 시장

Women´s Health Diagnostics
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 173 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

여성 건강 진단 시장은 2030년까지 439억 달러에 달한다

2023년에 297억 달러로 추정된 여성 건강 진단 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 5.7%로 성장하고, 2030년에는 439억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 유방암 검사 애플리케이션은 복합 연간 성장률(CAGR) 7.3%로 성장을 지속하고, 분석 기간 종료 시에는 113억 달러에 달할 것으로 예측됩니다. 감염성 검사 응용 분야의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 4.7%로 추정됩니다.

미국 시장은 79억 달러로 추정, 중국은 복합 연간 성장률(CAGR) 9.9%로 성장할 것으로 예측됩니다.

미국 여성 건강 진단 시장은 2023년 79억 달러로 추정됐습니다. 세계의 2위 경제대국인 중국은 2030년까지 106억 달러 규모에 이를 것으로 예측되며 예측 기간 동안 복합 연간 성장률(CAGR)은 9.9%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 2.2%와 5.8%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 2.8%로 성장할 것으로 예측됩니다.

세계의 여성 건강 진단 시장 - 주요 동향과 촉진요인 요약

왜 여성의 건강 진단이 건강 관리로 각광받는가?

유방암, 자궁 경부암, 골다공증, 생식기 질환 등, 주로 여성이 이환하는 질환의 조기 발견, 예방, 관리에 대한 의식의 고조와 주목에 의해 헬스 케어에 있어서 여성용 건강 진단이 각광을 받고 있습니다. 이러한 진단제에는 영상 진단, 분자진단, 포인트 오브 케어 검사, 실험실 기반 분석 등 다양한 라이프 스테이지에 걸쳐 여성의 건강을 모니터링하고 관리하기 위한 광범위한 검사 및 스크리닝 방법이 포함됩니다. 맞춤형 의료, 예방 의료, 환자 중심 접근법이 점점 더 중요해지고 있는 가운데 여성 건강 진단은 세계의 여성의 건강 결과와 삶의 질을 향상시키는 데 필수적인 요소가 되고 있습니다.

어떤 혁신이 여성의 건강 진단에 변화를 가져올 것인가?

분자진단, 영상 진단 및 요점 점검 기술의 진보는 여성의 건강 진단에 큰 변화를 가져왔습니다. 차세대 시퀀싱(NGS), 리퀴드 바이옵시, 동반진단의 개발에 의해 유전자 변이, 암, 기타 건강 상태를 보다 정확하고 비침습적으로 검출할 수 있게 되어, 보다 적당한 치료나 개인화된 치료 계획으로 이어집니다. 3D 유방 조영술, 초음파, 자기 공명 영상법(MRI)과 같은 영상 기술의 혁신은 유방 조직을 보다 정확하고 상세하게 시각화하여 유방암의 조기 발견 및 진단을 강화하고 있습니다. 또한 AI 주도 분석, 디지털 병리학 및 원격 의료 통합은 여성 건강 진단의 접근성, 효율성 및 정확성을 향상시켜 환자에게 친화적이고 비용 효율적입니다.

여성의 건강 진단 시장에서의 과제와 기회란?

여성 건강 진단 시장은 고급 진단 검사 비용, 저소득 지역의 고품질 건강 관리에 대한 제한된 접근, 여성 건강 문제에 대한 인식과 교육 개선의 필요성 등 여러 문제에 직면하고 있습니다. 또한 진단 검사의 규제 상황과 상환 상황도 복잡하고 시간이 걸립니다. 그러나 이러한 도전은 성장과 혁신의 큰 기회가되었습니다. 암, 심혈관 질환, 골다공증 등 만성 질환의 유병률 증가가 조기 발견과 예방 진단 수요를 촉진하고 있습니다. 맞춤형 의료, 원격 의료 및 재택 검사의 상승은 혁신적이고 사용하기 쉽고 저렴한 솔루션을 제공하는 진단제 제조업체에게 새로운 성장 기회를 제공합니다. 게다가 여성 건강 옹호, 정부 이니셔티브, 공중 보건 캠페인에 대한 관심 증가는 종합적이고 통합적인 여성 건강 진단의 필요성을 증가시키고 있습니다.

무엇이 여성의 건강 진단 시장의 성장을 가속하고 있는가?

여성의 건강 진단 시장의 성장은 여성의 만성 질환이나 생활 습관병의 유병률 증가, 조기 발견이나 맞춤형 의료에 대한 수요 증가, 분자진단, 화상 진단, AI 주도의 분석에 있어서의 기술 진보 등, 몇 가지 요인에 의해 제공됩니다. 조기 발견, 비침습적 검사 및 표적 치료를 제공하는 종합적이고 정확한 진단 솔루션에 대한 요구는 건강 관리 제공업체와 환자가 여성의 건강 결과와 QOL 개선을 요구하면서 시장 수요를 크게 밀어 올립니다. 차세대 시퀀싱, 디지털 병리학, AI 주도형 진단, 원격 의료 등의 기술 혁신은 여성의 건강 진단 능력과 접근성을 높이고 건강 관리 전문가와 환자 모두에게 더욱 매력적입니다. 예방의료 확대, 원격의료 및 재택검사의 성장, 여성의 건강 옹호와 의식 향상에 대한 주목 증가도 이해관계자가 여성의 건강을 위한 고도로 통합적인 진단 솔루션을 요구하고 있기 때문에 시장 성장을 가속하고 있습니다.

조사 대상 기업 예(주목의 41사)

  • Alere, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Quest Diagnostics, Inc.
  • Siemens AG

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.10.08

Global Women's Health Diagnostics Market to Reach US$43.9 Billion by 2030

The global market for Women's Health Diagnostics estimated at US$29.7 Billion in the year 2023, is expected to reach US$43.9 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Breast Cancer Testing Application, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$11.3 Billion by the end of the analysis period. Growth in the Infectious Disease Testing Application segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.9 Billion While China is Forecast to Grow at 9.9% CAGR

The Women's Health Diagnostics market in the U.S. is estimated at US$7.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$10.6 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Women’s Health Diagnostics Market - Key Trends & Drivers Summarized

Why Is Women’s Health Diagnostics Gaining Prominence in Healthcare?

Women’s health diagnostics is gaining prominence in healthcare due to the growing awareness and focus on early detection, prevention, and management of diseases that predominantly affect women, such as breast cancer, cervical cancer, osteoporosis, and reproductive health disorders. These diagnostics encompass a wide range of tests and screening methods, including imaging, molecular diagnostics, point-of-care testing, and lab-based assays, to monitor and manage women's health across different life stages. With the increasing emphasis on personalized medicine, preventive care, and patient-centric approaches, women’s health diagnostics are becoming essential for improving health outcomes and quality of life for women worldwide.

What Technological Innovations Are Transforming Women’s Health Diagnostics?

Technological advancements in molecular diagnostics, imaging, and point-of-care testing are significantly transforming women’s health diagnostics. The development of next-generation sequencing (NGS), liquid biopsy, and companion diagnostics is enabling more precise and non-invasive detection of genetic mutations, cancers, and other health conditions, leading to better-targeted therapies and personalized treatment plans. Innovations in imaging technologies, such as 3D mammography, ultrasound, and magnetic resonance imaging (MRI), are providing more accurate and detailed visualization of breast tissues, enhancing early detection and diagnosis of breast cancer. Additionally, the integration of AI-driven analytics, digital pathology, and telemedicine is improving the accessibility, efficiency, and accuracy of women’s health diagnostics, making them more patient-friendly and cost-effective.

What Are the Challenges and Opportunities in the Women’s Health Diagnostics Market?

The women’s health diagnostics market faces several challenges, including the high cost of advanced diagnostic tests, limited access to quality healthcare in low-income regions, and the need for increased awareness and education about women’s health issues. The regulatory and reimbursement landscape for diagnostic tests can also be complex and time-consuming. However, these challenges present significant opportunities for growth and innovation. The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and osteoporosis, is driving the demand for early detection and preventive diagnostics. The rise of personalized medicine, telehealth, and home-based testing is creating new growth opportunities for diagnostic manufacturers to offer innovative, accessible, and affordable solutions. Moreover, the growing focus on women’s health advocacy, government initiatives, and public health campaigns is driving the need for comprehensive and integrated women’s health diagnostics.

What Is Driving the Growth of the Women’s Health Diagnostics Market?

The growth in the Women’s Health Diagnostics market is driven by several factors, including the increasing prevalence of chronic and lifestyle-related diseases among women, rising demand for early detection and personalized medicine, and technological advancements in molecular diagnostics, imaging, and AI-driven analytics. The need for comprehensive and accurate diagnostic solutions that offer early detection, non-invasive testing, and targeted therapies is significantly boosting market demand as healthcare providers and patients seek to improve health outcomes and quality of life for women. Technological innovations such as next-generation sequencing, digital pathology, AI-driven diagnostics, and telemedicine are enhancing the capabilities and accessibility of women’s health diagnostics, making them more attractive to both healthcare professionals and patients. The expansion of preventive care, the growth of telehealth and home-based testing, and the increasing focus on women’s health advocacy and awareness are also driving market growth as stakeholders seek advanced and integrated diagnostic solutions for women’s health.

Select Competitors (Total 41 Featured) -

  • Alere, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Quest Diagnostics, Inc.
  • Siemens AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Women's Health Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases and Growing Awareness for Early Detection in Women
    • Increasing Demand for Point-of-Care and Home-Based Diagnostic Solutions
    • Advancements in Molecular Diagnostics and Next-Generation Sequencing for Women's Health
    • Growing Focus on Personalized Medicine and Companion Diagnostics for Targeted Therapies
    • Impact of Digital Health and Telemedicine on Women's Health Diagnostics Accessibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Women's Health Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Women's Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Breast Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Breast Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Breast Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Infectious Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cervical Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cervical Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Cervical Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Osteoporosis Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Osteoporosis Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Osteoporosis Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Prenatal Genetic Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Prenatal Genetic Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Prenatal Genetic Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pregnancy & Fertility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pregnancy & Fertility Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Diagnostic & Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • JAPAN
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • CHINA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • EUROPE
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Women's Health Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • FRANCE
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • GERMANY
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Women's Health Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • INDIA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: India 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Women's Health Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Women's Health Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • AFRICA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제